RUBY
Rubius Therapeutics, Inc
RUBY
RUBY
Delisted
RUBY was delisted on the 6th of March, 2023.
72 hedge funds and large institutions have $66.6M invested in Rubius Therapeutics, Inc in 2022 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 19 increasing their positions, 28 reducing their positions, and 58 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
72% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 58
87% less capital invested
Capital invested by funds: $494M → $66.6M (-$427M)
Holders
72
Holding in Top 10
2
Calls
$34K
Puts
$1K
Top Buyers
| 1 | +$605K | |
| 2 | +$345K | |
| 3 | +$333K | |
| 4 |
Two Sigma Investments
New York
|
+$288K |
| 5 |
Two Sigma Advisers
New York
|
+$262K |
Top Sellers
| 1 | -$16.2M | |
| 2 | -$5.45M | |
| 3 | -$2.29M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$2.13M |
| 5 |
BlackRock
New York
|
-$1.77M |